Funders › MI › Nf Forward › 2024
Grants paid by Nf Forward, tax year 2024
EIN 82-1672519 · Detroit, MI · Form 990, Schedule I · NTEE G12
In tax year 2024, Nf Forward (EIN 82-1672519) reported 18 grants paid totaling $14,742,234. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Children's Hospital of Philadelphia Philadelphia, PA | A | $3,023,731 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Stanford University Redwood City, CA | A | $2,492,685 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Children's Tumor Foundation New York, NY | A | $1,500,000 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | University of Alabama at Birmingham Birmingham, AL | A | $1,184,294 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Washington University St Louis, MO | A | $887,596 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Children's Hospital Corporation Boston, MA | A | $859,027 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Battelle Memorial Institute Columbus, OH | A | $619,262 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | University of Massachusetts Worcester, MA | A | $537,597 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | The General Hospital Corporation Boston, MA | A | $427,713 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | University of California San Francisco San Francisco, CA | A | $395,815 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Johns Hopkins University Baltimore, MD | A | $360,045 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Duke University Durham, NC | A | $360,000 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Trustees of Indiana University Bloomington, IN | A | $360,000 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Pennington Biomedical Research Center Baton Rouge, LA | A | $360,000 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | The Ohio State University Columbus, OH | A | $359,550 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Children's Hospital Medical Center Cincinnati, OH | A | $349,540 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | Virginia Commonwealth University Richmond, VA | A | $338,746 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
| 2024 | The Research Institute at Nationwide Columbus, OH | A | $326,633 | paid | SUPPORT FOR NEUROFIBROMATOSIS RESEARCH | 202533179349307923 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.